Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Learn about Visa credit cards that provide rewards without fees. Maximize your spending power and earn rewards effortlessly.
22,952 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Geopolitical tension around Iran is stirring market nerves. In this environment, bitcoin climbs even as stocks and go...
Two tech titans sit on sale, but only one may fit a patient investor's plan. This guide breaks down the case for Micr...
Antero Midstream logged 271% total returns over three years and closed a $1.1 billion Marcellus asset deal. The 2026 ...
A major fund recently added a huge stake in Neptune Insurance Holdings, boosting the quarter-end position by over $65...
Have tech stocks finally run out of road? This data-driven exploration breaks down valuations, growth drivers, and ho...
As AI demand reshapes chips, Intel and Arm sit at opposite ends of the risk spectrum. This analysis weighs which AI-e...
RAD Intel launches a Reg A+ offering at $0.91 per share, pitching its AI-driven marketing platform to scale Fortune 1...
Copper prices surge to multi-year highs as supply tightness persists. Four copper miners under $30 are showing signs ...
Three dividend-focused ETFs—VYM, SCHD and SPHD—could deliver roughly $7,300 per year from about 690 underlying stocks...
XRP remains under scrutiny as 2026 unfolds, with faster settlement times and evolving regulation shaping its appeal. ...
A strategic corporate split sparked surprising strength in a once-maverick stock. Learn why this stock business being...